Table 1.
The prevalence of HPV DNA positivity and cervical cytopathological findings of Iranian women according to the type of study
|
Population-based study |
Clinic-based study* |
|
|---|---|---|
| n = 799 | n = 200 | |
| PCR Positive for HPV DNA; n (%) |
5 (0.63%) |
11 (5.5%) |
| Pap test positive for HPV; n(%) |
9 (1.12%) |
9 (4.5%) |
| PCR and Pap Test Positive for HPV; n |
2 |
4 |
| Carcinogenic HPV genotypes |
16, 18, 31, 33, 51, 56 |
16, 18 |
| Probably carcinogenic HPV genotypes | 66 | 53 |
*Zandi et al. [12].